Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,929.17 -1,835.99 (-2.93%) CMC Crypto 200
1,261.13 -96.88 (-7.13%)
Annovis Bio, Inc. (ANVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.03 |
| Open | 6.13 |
| Bid | 5.98 x 1200 |
| Ask | 6.10 x 800 |
| Day's range | 5.40 - 6.35 |
| 52-week range | 4.79 - 22.49 |
| Volume | |
| Avg. volume | 494,455 |
| Market cap | 65.357M |
| Beta (5Y monthly) | 1.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.23 |
| Earnings date | 10 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 35.25 |
ZacksAmicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
Amicus (FOLD) reports first-quarter 2024 results, wherein earnings beat the Zacks Consensus Estimate but sales miss the same. The company updates its financial guidance for 2024.
ZacksXenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Xenon (XENE) reports better-than-expected first-quarter 2024 earnings. Its development programs for azetukalner in epilepsy and MDD are progressing well.
ZacksCatalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Catalyst (CPRX) reports first-quarter results, wherein earnings and revenues beat the Zacks Consensus Estimate, driven by strong Firdapse sales.
© 2024 Yahoo. All rights reserved.